Literature DB >> 23592668

Nonalcoholic fatty liver disease in severely obese adolescent and adult patients.

Ai-Xuan L Holterman1, Grace Guzman, Giamila Fantuzzi, Huaping Wang, Kristin Aigner, Allen Browne, Mark Holterman.   

Abstract

OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) is increasingly an indication for liver transplantation in adults. While severe obesity (SO, BMI ≥40 kg m(-2) ) in adults is long standing, it is recent in duration in adolescents. With adolescent obesity on the rise, NAFLD is becoming the most frequent liver disease in adolescents. The hypothesis that SO adolescents and adults have different severity of NAFLD because of longer duration of obesity in SO adults was tested. DESIGN AND METHODS: Preoperative clinical data, NAFLD activity and NASH (Nonalcoholic steatohepatitis) scores from intraoperative liver biopsies were extracted from a prospective database of consecutively operated SO adolescents and adults (n = 24 each). Fasting preoperative serum inflammatory mediators were evaluated by ELISA.
RESULTS: Other than age, baseline BMI, ethnicity and gender distribution, the incidence and extent of dyslipidemia, hypertension, and metabolic syndrome were comparable between groups. Histologic scores for steatosis and inflammation were similar. Adolescents have significantly higher NASH incidence, hepatocyte injury scores and fibrosis. This was associated with higher serum C-reactive protein and sCD14 levels.
CONCLUSION: For comparable BMI and metabolic profile, SO adolescents have more advanced liver damage, more severe systemic inflammation, suggesting differences in NAFLD etiologies and more aggressive disease progression in the young obese population.
Copyright © 2012 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23592668     DOI: 10.1002/oby.20174

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  33 in total

1.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

2.  Intraoperative Liver Biopsy During Adolescent Bariatric Surgery: Is It Really Necessary?

Authors:  R Ellen Jones; Ann Ming Yeh; Neerajah Kambham; Marwa Abu El Haija; Janey Pratt; Matias Bruzoni
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

3.  Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.

Authors:  Shinhiti Morita; Dalísio De Santi Neto; Flávio Hiroshi Ananias Morita; Nina Kimie Morita; Suzana Margareth Ajeje Lobo
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

4.  Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index).

Authors:  Anne-Marie Carreau; Laura Pyle; Yesenia Garcia-Reyes; Haseeb Rahat; Tim Vigers; Thomas Jensen; Ann Scherzinger; Kristen J Nadeau; Melanie Cree-Green
Journal:  Clin Endocrinol (Oxf)       Date:  2019-08-16       Impact factor: 3.478

5.  Relation between vitamin D status and nonalcoholic fatty liver disease in children.

Authors:  Suchitra K Hourigan; Stephanie Abrams; Katherine Yates; Kim Pfeifer; Michael Torbenson; Karen Murray; Christian L Roth; Kris Kowdley; Ann O Scheimann
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-03       Impact factor: 2.839

Review 6.  "Weighing the risk": Obesity and outcomes following liver transplantation.

Authors:  Trevor W Reichman; George Therapondos; Maria-Stella Serrano; John Seal; Rachel Evers-Meltzer; Humberto Bohorquez; Ari Cohen; Ian Carmody; Emily Ahmed; David Bruce; George E Loss
Journal:  World J Hepatol       Date:  2015-06-18

7.  Hepatic macrosteatosis in the US pediatric deceased liver donor population.

Authors:  Joshua W Purvis; Babak J Orandi; Deepti Dhall; Chandler McLeod; Luz Helena Gutierrez Sanchez; Meagan Gray; Kayla Frey; Saulat S Sheikh; Robert M Cannon; Norah A Terrault; Cora E Lewis; Jayme E Locke
Journal:  Pediatr Transplant       Date:  2021-09-30

Review 8.  Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease.

Authors:  Peter R Baker; Jacob E Friedman
Journal:  J Clin Invest       Date:  2018-08-31       Impact factor: 14.808

Review 9.  The relationship between excessive dietary fructose consumption and paediatric fatty liver disease.

Authors:  Johanna K DiStefano; Gabriel Q Shaibi
Journal:  Pediatr Obes       Date:  2020-12-11       Impact factor: 3.910

10.  A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease.

Authors:  Sakil Kulkarni; Nadia Naz; Hongjie Gu; Janis M Stoll; Michael D Thompson; Brian J DeBosch
Journal:  Clin Obes       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.